ECLIPSE MEDCORP, LLC – Trademark Portfolio
Entity Type: 16
ECLIPSE MEDCORP, LLC holds 36 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 20 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 15 trademarks are registered and 2 are pending. Notable registered marks include V, EVIVE, ECLIPSE, VOTESSE, and ECLIPSE PRP. The owner is based in THE COLONY, TX.
5916 STONE CREEK DRIVE #120
THE COLONY, TX 75056
Showing of trademarks Trademarks
Trademark Classifications
ECLIPSE MEDCORP, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ECLIPSE MEDCORP, LLC have?
ECLIPSE MEDCORP, LLC has 36 U.S. trademarks filed with the USPTO. Of these, 15 registered, 2 pending, 8 abandoned, 11 cancelled.
What trademark classes does ECLIPSE MEDCORP, LLC file in?
ECLIPSE MEDCORP, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 7 (Machinery). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are ECLIPSE MEDCORP, LLC's most well-known trademarks?
ECLIPSE MEDCORP, LLC's registered trademark portfolio includes well-known marks such as V, EVIVE, ECLIPSE, VOTESSE, and ECLIPSE PRP. These are among 15 currently registered trademarks in the portfolio.
What is ECLIPSE MEDCORP, LLC's trademark registration success rate?
ECLIPSE MEDCORP, LLC has a 44% trademark registration rate, with 15 out of 34 resolved applications resulting in successful registration. Currently, 2 applications are pending review.